Macrophage traits in cancer cells are induced by macrophage-cancer cell fusion and cannot be explained by cellular interaction

BMC Cancer

Volumn 15, Issue 1, 2015, Pages

  Shabo, Ivan ^a,b,c,d   Midtbö, Kristine ^a   Andersson, Henrik ^a   Åkerlund, Emma ^a   Olsson, Hans ^a   Wegman, Pia ^a   Gunnarsson, Cecilia ^a   Lindström, Annelie ^a  

^a LINKÖPING UNIVERSITY   (Sweden)

^b Regional Cancer Centre Southeast   (Sweden)

^c KAROLINSKA INSTITUTE   (Sweden)

^d KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Cell fusion; Macrophages; Paracrine cellular interaction; Tumor markers

Indexed keywords

CD163 ANTIGEN; GREEN FLUORESCENT PROTEIN; CELL SURFACE RECEPTOR; DIFFERENTIATION ANTIGEN; LEUKOCYTE ANTIGEN;

ANTIGEN EXPRESSION; ARTICLE; BREAST CANCER; CANCER CELL; CANCER SURVIVAL; CELL CLONE; CELL FUSION; CELL GROWTH; CELL INTERACTION; CELL ISOLATION; CELL LABELING; COCULTURE; CONTROLLED STUDY; DISEASE FREE SURVIVAL; FEMALE; FLOW CYTOMETRY; FLUORESCENCE ACTIVATED CELL SORTING; FLUORESCENCE MICROSCOPY; GENETIC TRAIT; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MACROPHAGE; MACROPHAGE ACTIVATION; MAJOR CLINICAL STUDY; MALE; MCF 7 CELL LINE; MONOCYTE; OVERALL SURVIVAL; PARACRINE SIGNALING; PHENOTYPE; REFERENCE VALUE; SHORT TANDEM REPEAT; BREAST TUMOR; CELL CULTURE; CYTOLOGY; MCF-7 CELL LINE; METABOLISM; PATHOLOGY; SURVIVAL ANALYSIS;

ANTIGENS, CD; ANTIGENS, DIFFERENTIATION, MYELOMONOCYTIC; BREAST NEOPLASMS; CELL FUSION; CELLS, CULTURED; COCULTURE TECHNIQUES; FEMALE; HUMANS; MACROPHAGES; MALE; MCF-7 CELLS; MONOCYTES; PARACRINE COMMUNICATION; PHENOTYPE; RECEPTORS, CELL SURFACE; SURVIVAL ANALYSIS;

EID: 84947745756     PISSN: None     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/s12885-015-1935-0     Document Type: Article

References (31)

1. Pawelek JM, Chakraborty AK. Fusion of tumour cells with bone marrow-derived cells: a unifying explanation for metastasis. Nat Rev Cancer. 2008;8(5):377-86.
2. Terada N, Hamazaki T, Oka M, Hoki M, Mastalerz DM, Nakano Y, et al. Bone marrow cells adopt the phenotype of other cells by spontaneous cell fusion. Nat. 2002;416(6880):542-5.
3. Yamanaka S, Blau HM. Nuclear reprogramming to a pluripotent state by three approaches. Nat. 2010;465(7299):704-12.
4. Pavlath GK, Blau HM. Expression of muscle genes in heterokaryons depends on gene dosage. J Cell Biol. 1986;102(1):124-30.
5. Rachkovsky M, Sodi S, Chakraborty A, Avissar Y, Bolognia J, McNiff JM, et al. Melanoma x macrophage hybrids with enhanced metastatic potential. Clin Exp Metastasis. 1998;16(4):299-312.
6. Busund LT, Killie MK, Bartnes K, Seljelid R. Spontaneously formed tumorigenic hybrids of Meth A sarcoma and macrophages grow faster and are better vascularized than the parental tumor. Int J Cancer. 2002;100(4):407-13.
7. Powell AE, Anderson EC, Davies PS, Silk AD, Pelz C, Impey S, et al. Fusion between Intestinal epithelial cells and macrophages in a cancer context results in nuclear reprogramming. Cancer Res. 2011;71(4):1497-505.
8. Silk AD, Gast CE, Davies PS, Fakhari FD, Vanderbeek GE, Mori M, et al. Fusion between hematopoietic and epithelial cells in adult human intestine. PLoS One. 2013;8(1), e55572.
9. Clawson GA, Kimchi E, Patrick SD, Xin P, Harouaka R, Zheng S, et al. Circulating tumor cells in melanoma patients. PLoS One. 2012;7(7), e41052.
10. Shabo I, Olsson H, Sun XF, Svanvik J. Expression of the macrophage antigen CD163 in rectal cancer cells is associated with early local recurrence and reduced survival time. Int J Cancer. 2009.
11. Shabo I, Stal O, Olsson H, Dore S, Svanvik J. Breast cancer expression of CD163, a macrophage scavenger receptor, is related to early distant recurrence and reduced patient survival. Int J Cancer. 2008;123(4):780-6.
12. Wyckoff J, Wang W, Lin EY, Wang Y, Pixley F, Stanley ER, et al. A paracrine loop between tumor cells and macrophages is required for tumor cell migration in mammary tumors. Cancer Res. 2004;64(19):7022-9.
13. Mallepell S, Krust A, Chambon P, Brisken C. Paracrine signaling through the epithelial estrogen receptor alpha is required for proliferation and morphogenesis in the mammary gland. Proc Natl Acad Sci U S A. 2006;103(7):2196-201.
14. Shabo I, Olsson H, Stal O, Svanvik J. Breast Cancer Expression of DAP12 is Associated With Skeletal and Liver Metastases and Poor Survival. Clin Breast Cancer. 2013;13(5):371-7.
15. Group SBCC. Randomized trial of two versus five years of adjuvant tamoxifen for postmenopausal early stage breast cancer. Swedish Breast Cancer Cooperative Group. J Natl Cancer Inst. 1996;88(21):1543-9.
16. Bjerregaard B, Holck S, Christensen IJ, Larsson LI. Syncytin is involved in breast cancer-endothelial cell fusions. Cell Mol Life Sci. 2006;63(16):1906-11.
17. Busund LT, Killie MK, Bartnes K, Seljelid R. Spontaneously formed tumorigenic hybrids of Meth A sarcoma cells and macrophages in vivo. Int J Cancer. 2003;106(2):153-9.
18. Maniecki MB, Etzerodt A, Ulhoi BP, Steiniche T, Borre M, Dyrskjot L, et al. Tumor-promoting macrophages induce the expression of the macrophage-specific receptor CD163 in malignant cells. Int J Cancer. 2012;131(10):2320-31.
19. Hendrix A, Hume AN. Exosome signaling in mammary gland development and cancer. Int J Dev Biol. 2011;55(7-9):879-87.
20. Tyan S-W, Kuo W-H, Huang C-K, Pan C-C, Shew J-Y, Chang K-J, et al. Breast Cancer Cells Induce Cancer-Associated Fibroblasts to Secrete Hepatocyte Growth Factor to Enhance Breast Tumorigenesis. PLoS One. 2011;6(1):e15313.
21. Hagemann T, Wilson J, Kulbe H, Li NF, Leinster DA, Charles K, et al. Macrophages induce invasiveness of epithelial cancer cells via NF-kappa B and JNK. J Immunol. 2005;175(2):1197-205.
22. Yang M, Chen J, Su F, Yu B, Su F, Lin L, et al. Microvesicles secreted by macrophages shuttle invasion-potentiating microRNAs into breast cancer cells. Mol Cancer. 2011;10:117.
23. Paululat A, Holz A, Renkawitz-Pohl R. Essential genes for myoblast fusion in Drosophila embryogenesis. Mech Dev. 1999;83(1-2):17-26.
24. Zhou X, Platt JL. Molecular and cellular mechanisms of mammalian cell fusion. Adv Exp Med Biol. 2011;713:33-64.
25. DeVita Jr VT, Young RC, Canellos GP. Combination versus single agent chemotherapy: a review of the basis for selection of drug treatment of cancer. Cancer. 1975;35(1):98-110.
26. Del Monte U. Does the cell number 10(9) still really fit one gram of tumor tissue? Cell cycle (Georgetown, Tex). 2009;8(3):505-6.
27. Carter CL, Allen C, Henson DE. Relation of tumor size, lymph node status, and survival in 24,740 breast cancer cases. Cancer. 1989;63(1):181-7.
28. Miller FR, McInerney D, Rogers C, Miller BE. Spontaneous fusion between metastatic mammary tumor subpopulations. J Cell Biochem. 1988;36(2):129-36.
29. Broyles RH, Roth AC, Todd M, Belegu V. Nuclear reprogramming by cell fusion. Methods Mol Biol. 2006;325:47-57.
30. Beerenwinkel N, Antal T, Dingli D, Traulsen A, Kinzler KW, Velculescu VE, et al. Genetic progression and the waiting time to cancer. PLoS Comput Biol. 2007;3(11):e225.
31. Tada M, Tada T. Epigenetic reprogramming of somatic genomes by electrofusion with embryonic stem cells. Methods Mol Biol. 2006;325:67-79.